FDA Inspection
Gland Pharma LimitedGland Pharma Limited – FDA Inspection, Jan 27, 2023
Record Details
This FDA Inspection record concerns Gland Pharma Limited, with an inspection on January 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3204a6bf-ba56-427c-bce5-3387799260ad
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1199204
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Gland Pharma Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2025 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| May 24, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 29, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gland Pharma Limited
- FDA Inspection 1261860 - 2025-02-25
- FDA Inspection 1245692 - 2024-05-24
- FDA Inspection 1052383 - 2018-04-20
- FDA Inspection 951916 - 2015-10-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.